Literature DB >> 32143312

Transformation of Helicobacter pylori into Coccoid Forms as a Challenge for Research Determining Activity of Antimicrobial Substances.

Paweł Krzyżek1, Rossella Grande2,3.   

Abstract

Morphological variability is one of the phenotypic features related to adaptation of microorganisms to stressful environmental conditions and increased tolerance to antimicrobial substances. Helicobacter pylori, a gastric mucosal pathogen, is characterized by a high heterogeneity and an ability to transform from a spiral to a coccoid form. The presence of the coccoid form is associated with the capacity to avoid immune system detection and to promote therapeutic failures. For this reason, it seems that the investigation for new, alternative methods combating H. pylori should include research of coccoid forms of this pathogen. The current review aimed at collecting information about the activity of antibacterial substances against H. pylori in the context of the morphological variability of this bacterium. The collected data was discussed in terms of the type of substances used, applied research techniques, and interpretation of results. The review was extended by a polemic on the limitations in determining the viability of coccoid H. pylori forms. Finally, recommendations which can help in future research aiming to find new compounds with a potential to eradicate H. pylori have been formulated.

Entities:  

Keywords:  H. pylori; antibacterial therapies; coccoid forms; morphological transformation

Year:  2020        PMID: 32143312     DOI: 10.3390/pathogens9030184

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  6 in total

1.  Toxin-Antitoxin Systems - A New Player in Morphological Transformation of Antibiotic-Exposed Helicobacter pylori?

Authors:  Paweł Krzyżek
Journal:  Front Cell Infect Microbiol       Date:  2021-04-26       Impact factor: 5.293

2.  In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori.

Authors:  Maciej Spiegel; Paweł Krzyżek; Ewa Dworniczek; Ryszard Adamski; Zbigniew Sroka
Journal:  Molecules       Date:  2021-12-21       Impact factor: 4.411

Review 3.  Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms.

Authors:  Hyelnaya Cletus Sharndama; Ifeanyi Elibe Mba
Journal:  Braz J Microbiol       Date:  2022-01-06       Impact factor: 2.476

4.  Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against Helicobacter pylori.

Authors:  Paweł Krzyżek; Paweł Migdał; Emil Paluch; Magdalena Karwańska; Alina Wieliczko; Grażyna Gościniak
Journal:  Int J Mol Sci       Date:  2021-03-07       Impact factor: 6.208

5.  Antibiotics as a Stressing Factor Triggering the Harboring of Helicobacter pylori J99 within Candida albicans ATCC10231.

Authors:  Kimberly Sánchez-Alonzo; Libnny Belmar; Cristian Parra-Sepúlveda; Humberto Bernasconi; Víctor L Campos; Carlos T Smith; Katia Sáez; Apolinaria García-Cancino
Journal:  Pathogens       Date:  2021-03-23

6.  Efficacy and safety of bismuth quadruple regimens containing tetracycline or furazolidone for initial eradication of Helicobacter pylori.

Authors:  Junxian Wang; Yuping Cao; Wei He; Xiaoping Li
Journal:  Medicine (Baltimore)       Date:  2021-12-23       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.